ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,898Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 917

$539K Total Retail Price of All Prescriptions

Rank: 98 out of 917

471 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,495 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 501 448 1 1
SIMVASTATIN 424 392 2 2
LEVOTHYROXINE SODIUM 401 395 3 3
OMEPRAZOLE 353 319 4 4
HYDROCHLOROTHIAZIDE 311 277 5 9
WARFARIN SODIUM 306 306 6 10
FUROSEMIDE 251 236 7 7
HYDROCODONE-ACETAMINOPHEN 240 228 S3 8 6
AMLODIPINE BESYLATE 238 233 9 5
METFORMIN HCL 205 177 10 8
MIRTAZAPINE 191 168 11 39
ATORVASTATIN CALCIUM 190 172 12 14
CITALOPRAM HBR 188 148 13 15
METOPROLOL TARTRATE 184 169 14 11
GABAPENTIN 156 130 15 17
METOPROLOL SUCCINATE 149 149 16 18
TAMSULOSIN HCL 134 126 17 25
LOSARTAN POTASSIUM 132 131 18 13
POTASSIUM CHLORIDE 132 121 18 16
SERTRALINE HCL 129 128 20 24
OXYCODONE HCL 123 96 S2 21 27
GLYBURIDE 113 92 R 22 71
ATENOLOL 108 85 23 12
PREDNISONE 106 106 24 34
TRAZODONE HCL 104 89 25 22
PROAIR HFA 101 93 26 35
TRIAMTERENE-HCTZ 91 74 27 36
FLUTICASONE PROPIONATE 89 80 28 26
CARVEDILOL 86 85 29 33
FENTANYL 86 76 S2 29 58
PANTOPRAZOLE SODIUM 85 68 31 44
ADVAIR DISKUS 84 83 32 47
ALENDRONATE SODIUM 82 82 33 23
SPIRIVA 79 78 34 45
DILTIAZEM 24HR CD 78 77 35 95
ENALAPRIL MALEATE 76 70 36 79
LOVASTATIN 75 58 37 19
OXYCODONE-ACETAMINOPHEN 75 59 S2 37 46
QUETIAPINE FUMARATE 67 64 39 52
TRAMADOL HCL 67 67 39 28
CRESTOR 65 59 41 30
FINASTERIDE 65 53 41 77
NAPROXEN 64 48 43 107
TRIAMCINOLONE ACETONIDE 63 60 44 96
METHADONE HCL 60 25 S2 45 59
DIOVAN 58 54 46 49
CLOPIDOGREL 56 55 47 50
ROPINIROLE HCL 56 55 47 88
PRAVASTATIN SODIUM 55 55 49 20
PLAVIX 55 55 49 84
BENAZEPRIL HCL 54 54 51 80
GLIPIZIDE 53 53 52 40
MORPHINE SULFATE ER 53 28 S2 52 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.